Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00972270 · ClinicalTrials.gov registry record · Phase 3
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
A Phase 3 study, sponsored by Abiomed.
- Terminated
- Registry status
- Phase 3
- Development phase
- 1
- Enrollment target
NCT00972270: Clinical Trial Phase 3 study, sponsored by Abiomed.
NCT00972270 is a Phase 3 study that was terminated before completion, run by Abiomed. The registered enrollment target is 1 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00972270, a Phase 3 study, was terminated before completion, sponsored by Abiomed.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is a randomized trial investigating the use of the IMPELLA RECOVER LP 2.5 compared to Intra-aortic balloon pump (IABP) in patients with Acute Myocardial Infarction.
Primary Outcome
Composite rate of major adverse events within 30 days or hospital discharge.
Interventions
- DEVICE Impella LP 2.5
- DEVICE Intra-Aortic Balloon Pump
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-09 |
| Phase | Phase 3 |
Why NCT00972270 stopped before completion
NCT00972270 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Impella LP 2.5 is the first listed.
NCT00972270 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00972270 about?
NCT00972270 is a clinical study titled "Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability". This is a randomized trial investigating the use of the IMPELLA RECOVER LP 2.5 compared to Intra-aortic balloon pump (IABP) in patients with Acute Myocardial Infarction.
What is the current status of trial NCT00972270?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 1 participants. The study started on 2008-07. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00972270?
The interventions under investigation include: Impella LP 2.5 (DEVICE), Intra-Aortic Balloon Pump (DEVICE).
Who is sponsoring clinical trial NCT00972270?
This trial is sponsored by Abiomed, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00972270's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia